MSC EVs overexpressing miR-122 were used to downregulate domain-containing protein 10 (ADAM10), insulin-like growth factor 1 receptor (IGF1R), and cyclin G1 (CCNG1), three proteins implicated in hepatocellular carcinoma. This evidence concerns the gene CCNG1 and hepatocellular carcinoma.